Tarsus Pharmaceuticals, Inc.
Total Trades
117
Buys
3
Sells
98
Largest Trade
N/A
Insiders
13
Institutional Funds
193
Inst. Value
$1M+
Activist Filings
39
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Neervannan Seshadri | COO | SELL | $500K+ | 8K | $76.67 | Mar 5, 2026 |
| Whitfield Dianne C. | CHRO | SELL | $1M+ | 16K | $80.67 | Jan 6, 2026 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 6K | $82.51 | Dec 30, 2025 |
| Whitfield Dianne C. | CHRO | SELL | $500K+ | 7K | $80.10 | Dec 18, 2025 |
| LINK WILLIAM J PHD | Director | SELL | $1M+ | 23K | $81.26 | Dec 17, 2025 |
| Lin Elizabeth Yeu | Chief Medical Offi… | EXERCISE | N/A | 7K | — | Dec 17, 2025 |
| Lin Elizabeth Yeu | Chief Medical Offi… | SELL | $100K–$500K | 2K | $79.50 | Dec 17, 2025 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 6K | $55.37 | Sep 26, 2025 |
| LINK WILLIAM J PHD | Director | SELL | $1M+ | 27K | $57.00 | Sep 10, 2025 |
| Farrow Jeffrey S | See Remarks | SELL | $500K+ | 14K | $40.42 | Jun 18, 2025 |
| Farrow Jeffrey S | See Remarks | EXERCISE | N/A | 28K | — | Jun 18, 2025 |
| Lin Elizabeth Yeu | Chief Medical Offi… | EXERCISE | N/A | 3K | — | Jun 17, 2025 |
| Lin Elizabeth Yeu | Chief Medical Offi… | SELL | $15K–$50K | 1K | $41.08 | Jun 17, 2025 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $500K+ | 18K | $43.76 | Jun 11, 2025 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 6K | $50.00 | Mar 26, 2025 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $500K+ | 11K | $47.88 | Mar 21, 2025 |
| Neervannan Seshadri | COO | SELL | $100K–$500K | 8K | $47.89 | Mar 21, 2025 |
| Wahl Bryan | General Counsel | SELL | $100K–$500K | 10K | $47.88 | Mar 21, 2025 |
| Whitfield Dianne C. | CHRO | SELL | $100K–$500K | 7K | $47.88 | Mar 21, 2025 |
| Azamian Bobak R. | President/CEO and … | SELL | $1M+ | 24K | $48.03 | Mar 21, 2025 |
| Farrow Jeffrey S | See Remarks | SELL | $100K–$500K | 4K | $47.88 | Mar 21, 2025 |
| Farrow Jeffrey S | See Remarks | EXERCISE | N/A | 28K | — | Jun 20, 2024 |
| Farrow Jeffrey S | See Remarks | SELL | $100K–$500K | 10K | $27.47 | Jun 20, 2024 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $20.22 | Dec 29, 2023 |
| Trevejo Jose M. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $20.00 | Dec 22, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $500K+ | 40K | $20.27 | Dec 22, 2023 |
| Whitfield Dianne C. | CHRO | SELL | $100K–$500K | 8K | $16.31 | Dec 1, 2023 |
| Whitfield Dianne C. | CHRO | EXERCISE | N/A | 24K | — | Dec 1, 2023 |
| Wahl Bryan | General Counsel | SELL | $100K–$500K | 8K | $16.31 | Dec 1, 2023 |
| Wahl Bryan | General Counsel | EXERCISE | N/A | 24K | — | Dec 1, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $18.37 | Nov 17, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $13.24 | Oct 20, 2023 |
| Trevejo Jose M. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $18.00 | Oct 6, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $17.21 | Sep 22, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $17.23 | Aug 25, 2023 |
| Lin Elizabeth Yeu | Director | BUY | $100K–$500K | 10K | $16.80 | Aug 17, 2023 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $15K–$50K | 2K | $20.05 | Jul 21, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $1M+ | 104K | $20.01 | Jul 21, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 9K | $17.35 | Jul 14, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $18.63 | Jun 23, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 9K | $18.58 | Jun 16, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $50K–$100K | 3K | $20.01 | Jun 12, 2023 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $1K–$15K | 100 | $20.00 | Jun 12, 2023 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $50K–$100K | 5K | $19.00 | Jun 8, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $15.90 | May 19, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 9K | $16.80 | May 12, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 10K | $15.11 | May 2, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $15K–$50K | 2K | $15.03 | Apr 25, 2023 |
| Greenstein Leonard M. | CFO | SELL | $50K–$100K | 5K | $14.02 | Apr 21, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $13.60 | Apr 21, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 193 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Deep Track Capital, LP | 3.0M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 1.9M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 1.2M | $1M+ | SH |
| Assenagon Asset Management S.A. | 1.1M | $1M+ | SH |
| STATE STREET CORP | 929K | $1M+ | SH |
| LORD, ABBETT & CO. LLC | 836K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 822K | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 729K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 585K | $1M+ | SH |
| TORONTO DOMINION BANK | 510K | $1M+ | SH |
| Clearbridge Investments, LLC | 506K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 474K | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 361K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 356K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 333K | $1M+ | SH |
| TimesSquare Capital Management, LLC | 332K | $1M+ | SH |
| MPM BioImpact LLC | 329K | $1M+ | SH |
| Cormorant Asset Management, LP | 250K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 173K | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 162K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
2.8%
1.2M shares
SC 13G/A · Nov 14, 2025
7.1%
3.0M shares
SC 13G/A · Aug 14, 2025
8.1%
3.4M shares
SC 13G · Jul 28, 2025
5.6%
2.4M shares
SC 13G/A · May 15, 2025
5.9%
2.5M shares
SC 13G/A · May 7, 2025
4.7%
1.9M shares
SC 13G/A · Apr 24, 2025
7.4%
3.1M shares
SC 13G/A · Feb 13, 2025
4.9%
1.9M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
6.4%
2.4M shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2024
1.3%
500K shares
SC 13G/A · Nov 12, 2024
5.5%
2.1M shares
Jennison Associates LLC IRS Identification #52-2069785 (formerly 13-2631108)
SC 13G · Nov 12, 2024
5.7%
2.2M shares
SC 13G/A · Nov 8, 2024
9.9%
3.8M shares
Frazier Life Sciences IX, L.P . 2.
SC 13G/A · Nov 6, 2024
4.2%
1.6M shares
SC 13G/A · Nov 4, 2024
5.5%
2.1M shares
SC 13G/A · Oct 21, 2024
9.9%
3.8M shares
SC 13G/A · Feb 14, 2024
6.7%
2.2M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
4.8%
1.6M shares
SC 13G/A · Feb 14, 2024
9.5%
3.2M shares
SC 13G/A · Feb 13, 2024
2.7%
895K shares
Cowen Financial Products LLC 27-0423711
SC 13G/A · Feb 2, 2024
5.8%
1.9M shares
SC 13G · Jan 26, 2024
7.6%
2.5M shares
Paradigm BioCapital Advisors LP
SC 13G · Jan 22, 2024
5.8%
1.9M shares
Cowen Financial Products LLC 27-0423711
SC 13G · May 5, 2023
5.2%
1.4M shares
SC 13G/A · Feb 14, 2023
7.5%
2.0M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2023
4.2%
1.1M shares
SC 13G/A · Feb 14, 2023
4.9%
1.3M shares
SC 13G/A · Feb 14, 2023
9.6%
2.5M shares
SC 13G/A · Feb 13, 2023
8.5%
2.3M shares
SC 13G/A · Feb 10, 2023
5.0%
1.3M shares
SC 13G · May 13, 2022
7.9%
2.1M shares
SC 13G · May 11, 2022
5.0%
1.3M shares
SC 13G/A · Feb 14, 2022
6.3%
1.3M shares
SC 13G/A · Feb 14, 2022
6.8%
1.4M shares
SC 13G/A · Feb 14, 2022
6.1%
1.3M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
3.7%
765K shares
SC 13G/A · Feb 14, 2022
9.7%
2.0M shares
SC 13G/A · Feb 11, 2022
14.4%
3.0M shares
Frazier Life Sciences IX, L.P.
SC 13G/A · Jan 28, 2022
6.9%
1.4M shares